Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease

Journal of Vascular Surgery

Volumn 43, Issue 4, 2006, Pages 772-780

  Musicant, Scott E ^a   Taylor Jr , Lloyd M ^a   Peters, Dawn ^a   Schuff, Robert A ^a   Urankar, Rakhee ^a   Landry, Gregory J ^a   Moneta, Gregory L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER;

ADULT; AGED; AMPUTATION; ANAMNESIS; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART INFARCTION; HUMAN; LIFE TABLE METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; STROKE; UNIVARIATE ANALYSIS;

AGED; ANALYSIS OF VARIANCE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33645768996     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2005.12.051     Document Type: Article

References (22)

1. Criqui M.H., Denenberg J.O., Langer R.D., and Fronek A. The epidemiology of peripheral arterial disease. importance of identifying the population at risk. Vasc Med 2 (1997) 221-226
2. Taylor L.M., Moneta G.L., Sexton G.J., Schuff R.A., and Porter J.M. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29 (1999) 8-21
3. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis. JAMA 285 (2002) 2481-2485
4. Hackman D.G., and Anand S.S. Emerging risk factors for atherosclerotic vascular disease. a critical review of the evidence. JAMA 290 (2003) 932-940
5. Lee A.J., Fowkes F.G.R., Lowe G.D.O., and Rumley A. Fibrin D-dimer, haemostatic factors and peripheral arterial disease. Thromb Haemost 74 (1995) 828-832
6. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 (2004) 2599-2610
7. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reative protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
8. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
9. Garcia B.A., Ruiz C., Chacon P., Sabin J.A., and Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis. risk marker for unstable carotid plaque. J Vasc Surg 38 (2003) 1018-1024
10. Dósa E., Rugonfalvi-Kiss S., Prohászka Z., Szabó A., Karádi I., Selmeci L., et al. Marked decrease in the levels of two inflammatory markers, hs-C-reative protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res 53 (2004) 631-635
11. Lowe G.D.O., Yarnell J.W., Rumley A., Bainton D., and Sweetnam P.M. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell Study. Arterioscler Thromb Vasc Biol 21 (2001) 603-610
12. McDermott M.M., Green D., Greenland P., Liu K., Criqui M.H., Chan C., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 92 (2003) 194-199
13. van der Bom J.G., Bots M.L., Haverkate F., Meijer P., Hofman A., Kluft C., et al. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral vascular disease. Thromb Haemost 85 (2001) 234-239
14. Smith F.B., Lee A.J., Hau C.M., Rumley A., Lowe G.D., and Fowkes F.G. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coag Fibrinol 11 (2000) 43-50
15. McDermott M.M., Greenland P., Guralnik J.M., Ferrucci L., Green D., Liu K., et al. Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity in patients with peripheral arterial disease. Vasc Med 9 (2004) 107-115
16. McDermott M.M., Greenland P., Green D., Guralnik J.M., Criqui M.H., Liu K., et al. D-dimer, inflammatory markers and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 107 (2003) 3191-3198
17. Baur G.M., Zupan T.L., Holmgren-Gates K., and Porter J.M. Blood flow in the common femoral artery. Am J Surg 145 (1983) 585-588
18. Strandness Jr. D.E. Extracranial arterial disease. In: Strandness Jr. D.E. (Ed). Duplex scanning in vascular disorders. 2nd edition (1993), Raven Press, New York 113-158
19. Yeager R.A., Taylor Jr. L.M., and Porter J.M. The present status of infrainguinal arterial reconstructive surgery for chronic lower extremity ischemia. Curr Prob Surg 28 (1991) 125-139
20. North American Symptomatic Carotid Endarterectomy (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial. methods, patient characteristics and progress. Stroke 22 (1991) 711-720
21. Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 20 (1989) 844-849
22. McDermott M.M., Guralnik J.M., Greenland P., Green D., Liu K., Ridker P.M., et al. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc 52 (2004) 1888-1894